title: Maternal interleukin-6: marker of fetal growth and adiposity.
abstract: Fetal overgrowth and higher adiposity are hallmarks of pregnancy with maternal obesity and poor glucose tolerance, two conditions associated with decreased maternal insulin sensitivity. In non-pregnant individuals, adipokines, vasoactive peptides, and components of the immune system crosstalk with metabolic factors to generate signals triggering obesity and impaired insulin action. We have investigated circulating maternal and fetal cytokines and growth-factors as potential biochemical markers of fetal adiposity. Mothers and neonates were classified into three tertiles (T1-T3) using total neonatal fat mass as the outcome with 309 +/- 25 g in T1, 478 +/- 40 g in T2, and 529 +/- 39 g in T3. Umbilical cord endothelin-1 (ET-1), C-peptide, and leptin were higher in T3 and T2 versus T1. Only cord leptin was strongly associated with fetal fat mass (P < .01), whereas neonatal lean body mass was negatively correlated with maternal insulin-like growth factor binding protein-I (IGFBP-I) (r = -0.53, P < .04). This study shows an association between increased fetal adiposity and maternal systemic interleukin-6 (IL-6). No such correlation was found with factors circulating in cord blood, suggesting that the stimuli favoring fetal fat accretion derive from maternal or placental sources rather than from the fetus.
authors.affiliation: Case Western, Cleveland, OH 44109, USA.
authors.forename: Tatjana
authors.initials: T
authors.lastname: Radaelli
authors.forename: Jennifer
authors.initials: J
authors.lastname: Uvena-Celebrezze
authors.forename: Judi
authors.initials: J
authors.lastname: Minium
authors.forename: Larraine
authors.initials: L
authors.lastname: Huston-Presley
authors.forename: Patrick
authors.initials: P
authors.lastname: Catalano
authors.forename: Sylvie
authors.initials: S
authors.lastname: Hauguel-de Mouzon
mesh_terms: D050154:Adiposity / Q000502:physiology*; D000328:Adult; D015415:Biomarkers / Q000097:blood*; D001786:Blood Glucose / Q000032:analysis / Q000378:metabolism; D016207:Cytokines / Q000097:blood; D005260:Female; D005312:Fetal Blood / Q000737:chemistry; D047109:Fetal Development; D006133:Growth Substances / Q000097:blood; D006801:Humans; D007231:Infant, Newborn; D007249:Inflammation; D007333:Insulin Resistance; D015850:Interleukin-6 / Q000097:blood*; D008297:Male; D009765:Obesity / Q000150:complications*; D011247:Pregnancy
chemical_list: D015415:Biomarkers; D001786:Blood Glucose; D016207:Cytokines; D006133:Growth Substances; D015850:Interleukin-6